Please click
 User   Pwd      Remember
Article Search: 
· Home
· About us
· Services
· Contact us
Info Resources
· Companies
· Institutes
· Science parks
· Life science news
· Company spotlight
· Taiwan bio report
· Feature articles
· Asia-Pacific events
· Investment corner
· Technology transfer
· Int'l biotech links
· Info resources search
· Job listings
· Log out

Previous  8 9 10 11 12 13 14 15 16 17 ... Total pages:258  Next 

Life Science News

(Taiwan) Academia Sinica reveals cancer research findings

(Taipei Times)

1 November, 2014
Academia Sinica yesterday unveiled the results of its research into the effects a protein complex has on the development of colorectal cancer, providing a possible solution to the treatment of the disease, which is the most common cancer in the nation.

Life Science News

(Taiwan) Gold NanoTech (GNT) medical devices subsidiary opens new headquarters, announces intl. and local partnership signings

(BiotechEast staff)

28 October, 2014
GNTbmd, the medical device and cosmetics subsidiary of Taipei, Taiwan-headquartered Gold NanoTech (GNT) Co., Ltd., held its official opening at its new location in the Nankang Biotechnology Plaza in Taipei on Friday. At the same time it announced the signing of alliance partnerships with devices firm Maxigen Biotechnology of Taipei, and boutique cosmetics company MV COSMETIQUES of Milan, Italy, with the two firms set to use GNT's gold nanoparticles in their products in a jointly-branded marketing arrangement for sale firstly in Taiwan and later China.

Life Science News

(Taiwan) Ebola could cost Taiwan US$200,000 per confirmed case

(Focus Taiwan)

24 October, 2014
If the Ebola epidemic spreads to Taiwan, each confirmed case could cost the government up to NT$6 million (US$197,000), the Centers for Disease Control (CDC) said Thursday.

Life Science News

(Taiwan) NCKU, University of Ottawa collaboration leads to medical breakthrough in ovarian cancer

(National Cheng Kung University News Center)

24 October, 2014
In a joint collaboration by research teams of National Cheng Kung University (NCKU) in southern Taiwan and the University of Ottawa in Canada a discovery has been made that will help clinicians to better treat women with ovarian cancer, NCKU has revealed.

Life Science News

(Taiwan) Tainan researchers unveil 'smart' card for blood tests

(China Post, Taiwan)

24 October, 2014
A research team at National Cheng Kung University in Tainan unveiled Thursday a pocket-sized blood test card that can identify blood type and finish cross-matching in just minutes.

Life Science News

(Taiwan) GNT and Penderyn Distillery of Wales launch special edition golden whisky in Taiwan

(BiotechEast staff)

20 October, 2014
At a press event on Saturday in Taipei's Huashan 1914 Creative Park, Taiwan's Gold NanoTech Inc. (GNT) together with Penderyn Distillery of Wales, UK, jointly launched a special release of Penderyn's single malt whisky infused with GNT's edible nano-gold flake for the Taiwan market.

Life Science News

(Taiwan) Ssu Cheng teams up with COA

(Taipei Times)

14 October, 2014
The Council of Agriculture (COA) yesterday authorized Ssu Cheng Biotech Co to use its pesticide residue rapid screening technology, signing an exclusive contract with the company worth NT$12 million (US$400,000).

Life Science News

(China) Vitafoods Asia Strengthens its Position in the Nutraceutical Industry

(Press release, Vitafoods Asia)

29 September, 2014
Vitafoods Asia, the only Pan-Asian event dedicated exclusively to the nutraceutical industry, recently concluded its fourth edition on a high note, reinforcing its status as the definitive exhibition for the market.

Life Science News

(China) Epirus, Livzon Mabpharm enter deal for five biosimilar products in China


26 September, 2014
US-based Epirus Biopharmaceuticals has signed a royalty-bearing, multi-product collaboration agreement with Livzon Mabpharm (Livzon), a Chinese biotechnology firm focused on the development, manufacture, and sale of antibody-based drugs.

Life Science News

(China) Shares In Chinese Billionaire's Pharmaceuticals Maker Soar 15% On Acquisition


28 September, 2014
Shares in Luye Pharmaceutical, a cancer drug maker led by Chinese billionaire Liu Dianbo, climbed by 15% at the Hong Kong Stock Exchange to a record high today after the company announced plans to buy a majority stake in Beijing Jialin Pharmaceutical.



Taiwan Life Sciences Bulletin

Enter email address to receive free e-newsletter


Disclaimer and Privacy Policy